Eliminate Roadblocks That Typically Slow Down Clinical Trials & Reduce Development Costs. Full-Service CRO W/ Capabilities For Diagnostic & Pharmaceutical Trials. Contact Us Today!
- Meet The Team
Our Team Has A Breadth Of Expertise
& Knowledge In The Life Sciences
- Contact Us
Tell Us More About What You're
Looking For. We Respond Within 48H
- Biobanx
Explore Boca Biolistics
high-quality biospecimens for ...
- Omicron Variant Specimens
A Robust Life Sciences
Biorepository With Industry ...
- About BioBanx
Learn More About Biobank,
Reference Lab & CRO.
- About Boca Biolistics
Learn More About Our Vision
To Drive Science Forward
- Meet The Team
Search results
Dec 24, 2021 · Molnupiravir is an anti-viral drug that disrupts Omicron's ability to replicate inside our bodies and cuts hospital admission by 30%. Sotrovimab is an antibody therapy that sticks to the virus and ...
Dec 23, 2021 · Of the 11 Omicron cases recorded in this round up to 11 December, 7 cases were symptomatic (5 with classic COVID-19 symptoms) and 2 were asymptomatic. The symptoms for the remaining 2 cases were ...
Dec 18, 2021 · A major incident has been declared in London and more than 10,000 new Omicron cases have been confirmed in the UK, as the variant surges across the country. A further 90,418 daily Covid cases have ...
- Overview
- Omicron daily overview: 31 December 2021
- Omicron daily overview: regional data
- Omicron daily overview: cumulative data
- Omicron daily overview: 30 December 2021
- Omicron daily overview: 29 December 2021
- Omicron daily overview: 28 December 2021
- Omicron daily overview: 27 December 2021
- Omicron daily overview: 24 December 2021
- Omicron daily overview: 23 December 2021
An overview and summary of case data for Omicron focusing on confirmed and SGTF cases in the UK.
Ref: GOV-10947
PDF, 2.81 MB, 7 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
CSV, 82.4 KB
View online
This file may not be suitable for users of assistive technology.
Request an accessible format.
CSV, 8.52 KB
View online
This file may not be suitable for users of assistive technology.
Request an accessible format.
Ref: GOV-10938
PDF, 2.72 MB, 7 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Ref: GOV-10927
PDF, 2.45 MB, 7 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Ref: GOV-10917
PDF, 1000 KB, 7 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Ref: GOV-10916
PDF, 2.71 MB, 7 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Ref: GOV-10909
PDF, 2.82 MB, 7 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Ref: GOV-10887
PDF, 2.18 MB, 7 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Jan 4, 2022 · The Omicron variant is a VoC because it has many mutations that haven't been seen before. A large number of these are on the part of the virus that most vaccines target - the spike protein.
Nov 28, 2021 · Update on Omicron. On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). This decision was based on the evidence presented to the TAG-VE that Omicron has several mutations that may have an impact on how it behaves, for example ...
Dec 15, 2021 · The new coronavirus variant Omicron is spreading across the globe at an unprecedented rate, the World Health Organization (WHO) has warned. Cases of the heavily mutated variant have been confirmed ...
